Search results for "cell therapy"

Article Cytiva and 4Tune Engineering Collaborate on Cell Therapy Quality Risk Management
…t they have entered into an agreement to include 4Tune Engineering’s iRISK platform in Cytiva’s cell therapy product offering. Cytiva customers in the early stages of cell therapy product developm…

Article Future-proof your AAV process with a complete producer cell line – just induce and grow
Stable producer cell lines helped to make mAb therapies the powerhouses they are today. To deliver on the promise of AAV-based gene therapy for prevalent diseases, we need similar technology. …

Article Getting Ahead of the Game in Cell and Gene Therapy
Successes in the clinic have placed many cell and gene therapies on an accelerated route to market. But unless developers consider, at an early stage, how they might produce their product at scale, th…

Resource Advanced Cell Therapy Technology Fast Trak Course (CELLT1)
This free webinar gives an overview of cell and gene therapy manufacturing and what the current landscape looks like.  

Article Production of Recombinant Adeno-associated Virus Vectors Using Microcarrier Culture of HEK293T Cells
As of March 2020, more than 4310 gene therapy clinical trials have been performed worldwide, with only 518 of them in Phase III and Phase IV. As the gene therapy projects enter clinical Phase III or g…

Article The Role of CDMOs in Cell and Gene Therapy Process Development
Click here to read more >> An experienced contract development and manufacturing organization (CDMO) can ease scaling and tech transfer.

Poster A Scalable Adenovirus Production Process, from Cell Culture to Purified Bulk
Adenovirus (AdV) vectors are commonly used in cancer gene therapy trials and evaluated for use in vaccines for various diseases. In this study, we have combined technical evaluation of process steps a…

Article From cells to purified capsids: How to develop a scalable rAAV process
Adeno-associated virus (AAV) is the most common vector for gene therapy, yet there’s much room to improve production, purification, and analytics. In this webinar we present the latest upd…

Article rAAV Production Using HEK293 Cell Line and Transfection Medium
  Improving the performance of a scalable AAV process in Xcellerex™ XDR-10 and XDR-200 bioreactor using HyClone™ peak expression medium. LEARN MORE >>

Article New Therapies Present Scaling Challenges
With a cell therapy, however, establishing cost-effective ways to commercially manufacture cell therapies for mainstream use remains a challenge. For a gene therapy, some aspects of its manufacturing …

Previous PageNext Page